JPWO2020102820A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020102820A5
JPWO2020102820A5 JP2021526521A JP2021526521A JPWO2020102820A5 JP WO2020102820 A5 JPWO2020102820 A5 JP WO2020102820A5 JP 2021526521 A JP2021526521 A JP 2021526521A JP 2021526521 A JP2021526521 A JP 2021526521A JP WO2020102820 A5 JPWO2020102820 A5 JP WO2020102820A5
Authority
JP
Japan
Prior art keywords
substituted
group
moiety
tacn
anionic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021526521A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022507519A5 (https=
JP2022507519A (ja
JP7582942B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/062077 external-priority patent/WO2020102820A1/en
Publication of JP2022507519A publication Critical patent/JP2022507519A/ja
Publication of JP2022507519A5 publication Critical patent/JP2022507519A5/ja
Publication of JPWO2020102820A5 publication Critical patent/JPWO2020102820A5/ja
Priority to JP2024163405A priority Critical patent/JP2024178308A/ja
Application granted granted Critical
Publication of JP7582942B2 publication Critical patent/JP7582942B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021526521A 2018-11-16 2019-11-18 アニオン性ペンダントおよび補助基を含む、鉄(iii)mri造影剤として使用するための化合物 Active JP7582942B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024163405A JP2024178308A (ja) 2018-11-16 2024-09-20 アニオン性ペンダントおよび補助基を含む、鉄(iii)mri造影剤として使用するための化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862768823P 2018-11-16 2018-11-16
US62/768,823 2018-11-16
PCT/US2019/062077 WO2020102820A1 (en) 2018-11-16 2019-11-18 Compounds for use as iron (iii) mri contrast agents containing anionic pendents and ancillary groups

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024163405A Division JP2024178308A (ja) 2018-11-16 2024-09-20 アニオン性ペンダントおよび補助基を含む、鉄(iii)mri造影剤として使用するための化合物

Publications (4)

Publication Number Publication Date
JP2022507519A JP2022507519A (ja) 2022-01-18
JP2022507519A5 JP2022507519A5 (https=) 2022-09-29
JPWO2020102820A5 true JPWO2020102820A5 (https=) 2022-09-29
JP7582942B2 JP7582942B2 (ja) 2024-11-13

Family

ID=70730921

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021526521A Active JP7582942B2 (ja) 2018-11-16 2019-11-18 アニオン性ペンダントおよび補助基を含む、鉄(iii)mri造影剤として使用するための化合物
JP2024163405A Pending JP2024178308A (ja) 2018-11-16 2024-09-20 アニオン性ペンダントおよび補助基を含む、鉄(iii)mri造影剤として使用するための化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024163405A Pending JP2024178308A (ja) 2018-11-16 2024-09-20 アニオン性ペンダントおよび補助基を含む、鉄(iii)mri造影剤として使用するための化合物

Country Status (7)

Country Link
US (1) US11344635B2 (https=)
EP (1) EP3880257A4 (https=)
JP (2) JP7582942B2 (https=)
KR (1) KR20210114932A (https=)
CN (1) CN113646009A (https=)
AU (1) AU2019381793B2 (https=)
WO (1) WO2020102820A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019381793B2 (en) * 2018-11-16 2025-02-27 The Research Foundation For The State University Of New York Compounds for use as iron (III) MRI contrast agents containing anionic pendents and ancillary groups
US20240228524A1 (en) * 2021-03-20 2024-07-11 The Research Foundation For The State University Of New York Iron(iii) macrocyclic complexes with mixed hyroxyl pendants as mri contrast agents
WO2024097160A1 (en) * 2022-10-31 2024-05-10 Yale University Transition metal complexes for mri applications and methods of use
CN121698848A (zh) * 2026-02-09 2026-03-20 浙江大学衢州研究院 一种具有三氮杂环壬烷大环骨架的铁配合物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2091251T3 (es) * 1989-11-27 1996-11-01 Concat Ltd Perfeccionamiento de la imagen en la mri del hueso y del tejido emparentado utilizando complejos de cationes paramagneticos y ligandos polifosfonato.
US5236695A (en) 1989-11-27 1993-08-17 Concat, Ltd. MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
US5409689A (en) 1993-08-13 1995-04-25 Concat, Ltd. MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms
EP0955044B1 (en) * 1995-06-26 2005-11-16 Chelator LLC Method of inhibiting bacterial or fungal growth using a complexing agent
US6264966B1 (en) 2000-02-22 2001-07-24 Concat, Ltd. Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury
US20050112066A1 (en) 2003-11-26 2005-05-26 Concat Lp, A California Limited Partnership Complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity
WO2012027727A2 (en) * 2010-08-26 2012-03-01 Kunyuan Cui Lipomacrocycles and uses thereof
WO2013060793A1 (en) 2011-10-25 2013-05-02 Technische Universität München Bifunctional ligands for radiometals
US10960088B2 (en) * 2013-09-12 2021-03-30 The Research Foundation For The State University Of New York Macrocycles, cobalt and iron complexes of same, and methods of making and using same
CN104119402B (zh) 2014-08-01 2016-08-24 南京大学 具有单分子磁行为和荧光精细结构的有机膦酸镝配合物
EP3624859A4 (en) * 2017-05-19 2021-03-03 The Research Foundation for The State University of New York Compounds for use as iron(iii) mri contrast agents
AU2019381793B2 (en) * 2018-11-16 2025-02-27 The Research Foundation For The State University Of New York Compounds for use as iron (III) MRI contrast agents containing anionic pendents and ancillary groups

Similar Documents

Publication Publication Date Title
JP2022507519A5 (https=)
US5236914A (en) Derivatives of metalloporphyrins and application thereof for therapeutic purposes and in preparing hybrid molecules
ES403883A1 (es) Procedimiento para la preparacion de compuestos de organo- silicio que contienen azufre.
JPWO2020102820A5 (https=)
SE8405710D0 (sv) Nya 6-vinyl-furo-(3,4-c)-pyridinderivat, framstellning derav och farmaceutiska kompositioner innehallande dem
JP2020520998A5 (https=)
JPS61143351A (ja) テクネチウム−99mとプロピレンアミンオキシムとの錯体
Modder et al. Structural features of silver (I) and copper (I) bis (thiophene-2-carbaldehyde imine) trifluoromethanesulfonate complexes in the solid state and in solution: crystal structures of [Ag {Th-2-CH: N-(S)-CHMePh} 2](O3SCF3) and [Cu {5-Me-Th-2-CH: N-iso-Pr} 2](O3SCF3) and a proton, fluorine-19 and silver-109 NMR study
Luo et al. Mixed azide and substituted 1, 2, 4-triazole co-ligand bridged 1D chain cadmium (II) motif: crystal structure, Hirshfeld surfaces and spectroscopic studies
GB1426392A (en) Nickel complexes fof hydroxy benzoic acids and their use as stabilisers for synthetic polymers
Mobian et al. Building [2] catenanes around a tris (diimine) ruthenium (2+)([Ru (diimine) 3] 2+) complex core used as template
Kato et al. Spectral and magnetic studies on bi-and tri-nuclear complexes derived from copper (II) complexes with tetradentate Schiff base and one of the chlorides, nitrates and perchlorates of copper (II), nickel (II), cobalt (II) and zinc (II)
Levason et al. Coordination complexes containing multidentate ligands. Part X. The reaction of divalent cobalt, nickel, and palladium salts with open-chain tetrathioethers, α, ω-bis (methylthioalkylthio) alkanes. The effect of chelate chain length on donor and spectral properties
Nesvadba et al. Oxidation of polysubstituted pyridinium salts
Banbery et al. The synthesis and X-ray crystal structure of the trinuclear complex [{ORe (OC6H4-2-CMe NCH2-) 2 (-μ-O)} 2Re (OC6H4-2-CMe NCH2-) 2] Cl· H2O· 0.5 CH2Cl2ag
IE881599L (en) Tetrahydrofurans and tetraydrothiophenes
Barbanente et al. Pt (ii) and Pt (iv) complexes with a major component of royal jelly as innovative antitumor drug candidates
JPH10231284A5 (https=)
Eremenko et al. Antiferromagnetic complexes with metal metal bonds: XXIV. Bi-and trinuclear cyclopentadienyl clusters of chromium with nitrene bridges
Araki et al. Adducts of a series of carbamato-silver (I) with tertiary phosphine: Synthesis and properties in solution
Solé et al. N, N-Dialkyl-2-iodoanilines: A versatile source for the synthesis of Pd (II) complexes. Synthesis of novel OCP-and CCN-pincer palladium complexes
GB1386210A (en) 2-methyl-5 nitro-1- 2-heteroaryloxy-ethyl imidazoles
Ghosh et al. Metal and solvent dependent formation of imidazolidine or hemiaminal ether complexes
Verdicchio Pyrazolone-based metal complexes: synthesis, characterization and theoretical study of Zn (II), Cu (II) and Mo (IV) derivatives
Poddar et al. Complexes of Sn (lV) with Schiff Bases Derived from Salicylaldehyde/Acetyl acetone & o-Aminophenol,-o-Aminobenzothi61 & o-Aminobenzoic Acid